MIC Blend (4X)

Human clinical Weight Loss & Metabolism 3 sources

MIC Blend (4X) is a concentrated combination of lipotropic agents—Methionine, Inositol, and Choline. These compounds work synergistically to support lipid metabolism, promote the export of fat from the liver, and enhance cellular energy production. Research indicates that lipotropic nutrients can aid in managing hepatic steatosis and supporting metabolic health, though clinical evidence for significant weight loss as a standalone treatment remains mixed.

01Dosing reference

Amount

0.5 - 1.0 mL (concentrated 4X formulation)

Frequency

1-2 times per week

Cycle

8-12 weeks on, followed by clinical reassessment

Reference figures, not a recommendationThese values reflect amounts described in the literature and vendor documentation this database indexes. Use the reconstitution calculator to convert them into syringe units.

02Mechanism of action

Lipotropic Action

Choline and Inositol act as lipotropic agents, facilitating the processing and export of fats from the liver.

VLDL Formation

Choline is used to synthesize phosphatidylcholine, a critical component of Very Low-Density Lipoproteins (VLDL) that transport triglycerides out of the liver.

Methylation and Detoxification

Methionine acts as a major methyl donor in the body, supporting detoxification pathways and the synthesis of other essential molecules like SAMe.

03Human evidence

Choline deficiency is directly linked to the development of non-alcoholic fatty liver disease (NAFLD), and supplementation can reverse hepatic steatosis.

Clinical studies observing patients on total parenteral nutrition without choline, and subsequent reversal of liver fat upon choline reintroduction.

Inositol supplementation significantly improves insulin sensitivity and metabolic markers.

Clinical trials in populations with insulin resistance, such as women with PCOS, showing improved metabolic profiles.

04Preclinical evidence

Combined supplementation of choline and inositol significantly reduces hepatic lipid accumulation compared to either nutrient alone.

Animal models of diet-induced hepatic steatosis evaluating the synergistic effects of lipotropic nutrients.

Methionine plays a complex role in metabolism, where adequate levels are necessary for proper lipid export from the liver and antioxidant defense.

Rodent studies examining the metabolic pathways of sulfur-containing amino acids.

05What is known vs. unknown

Reasonably established

Methionine is an essential amino acid that supports liver function, detoxification, and acts as a precursor to SAMe.
Inositol helps regulate insulin signaling, which can improve metabolic parameters and cellular energy utilization.
Choline is critical for lipid transport, specifically in preventing fat accumulation in the liver by aiding VLDL formation.
MIC blends are often administered via intramuscular or subcutaneous injection to bypass digestive breakdown and ensure high bioavailability.

Unknowns & limits

The exact efficacy of injectable MIC blends for significant weight loss in humans without concurrent dietary and lifestyle changes is not robustly proven.
Optimal dosing protocols and the specific clinical advantage of '4X' concentrated formulations over standard doses require more rigorous, large-scale clinical trials.

06Safety & regulatory context

Regulatory statusThe individual components of the MIC blend (Methionine, Inositol, Choline) are generally recognized as safe (GRAS) when consumed orally and are widely used in clinical settings as injectable lipotropics. Side effects are typically mild and may include injection site reactions, gastrointestinal upset, or a mild fishy body odor (due to choline metabolism). While the ingredients are well-established nutrients, compounded MIC injections are not FDA-approved as a specific combination drug for weight loss, but are legally compounded by pharmacies for metabolic support.

07Compared with L-Carnitine

MIC Blend (4X) vs. L-Carnitine

Key difference

MIC primarily focuses on mobilizing fat out of the liver and supporting liver health, whereas L-Carnitine specifically transports fatty acids into the mitochondria to be burned for energy.

When researchers discuss each

MIC is discussed in the context of liver health, lipotropic effects, and metabolic support, while L-Carnitine is highlighted for energy production, exercise performance, and mitochondrial fat oxidation.

08Glossary

Lipotropic

Compounds that help catalyze the breakdown of fat during metabolism in the body, particularly in the liver.

Hepatic Steatosis

The accumulation of excess fat in the liver, often referred to as fatty liver.

VLDL (Very Low-Density Lipoprotein)

A type of lipoprotein made by the liver that carries triglycerides to tissues for energy or storage.

09Knowledge check

Q1Which component of the MIC blend is primarily responsible for the synthesis of phosphatidylcholine, essential for exporting fat from the liver?

Q2What is the primary biological role of lipotropic agents like those found in the MIC blend?

Q3Which statement best reflects the dossier's interpretation of the evidence for injectable MIC blends producing substantial weight loss on their own?

Q4According to the dossier, in what research context is MIC most often discussed compared with L‑carnitine?

Q5Which statement accurately summarizes the dossier's safety and regulatory description of compounded MIC injections?

10Sources

More in Weight Loss & Metabolism

See all

AOD-9604

Weight Loss & Metabolism

Human clinical

AOD-9604 is a modified fragment of human growth hormone (HGH) that includes amino acids 177-191. Research indicates it mimics the fat-burning effects of HGH by stimulating lipolysis and inhibiting lipogenesis, without the adverse effects on blood sugar or tissue growth typically associated with full-length HGH.

250-500 mcg/day

MOTS-c

Weight Loss & Metabolism

Early human

MOTS-c is a naturally occurring mitochondrial-derived peptide that plays a key role in regulating metabolic homeostasis and energy production. Research indicates it acts as an 'exercise mimetic' by activating AMPK, improving insulin sensitivity, and enhancing physical performance in animal models.

5-10 mg

GLP3-RT (Retatrutide)

Weight Loss & Metabolism

Human clinical

Retatrutide is an investigational triple hormone receptor agonist that targets GLP-1, GIP, and glucagon receptors. Clinical trials have shown unprecedented weight loss efficacy, surpassing dual agonists, by combining appetite suppression with increased energy expenditure.

N/A - Investigational Drug

Research and educational use onlyNothing on this site is medical advice, a prescription, or a recommendation for human use. Compounds documented here are research chemicals. Consult a qualified clinician before making any health decision.